The coin-sized implant, cleared by the National Medical Products Administration in March, is now available for commercial use in treating paralysis from spinal cord injuries. Developed jointly by Neuracle Technology in Shanghai and researchers at Tsinghua University, it represents a milestone in neurotechnology that could transform care for thousands of patients.
The device enables people to control a soft robotic glove through thought alone, restoring basic hand movements such as grasping objects or writing. It is intended for adults aged 18 to 60 who have partial paralysis but retain some upper arm function, with the system already integrated into China's public health insurance to broaden access.
